Cencora Inc. (COR) - Total Assets
Based on the latest financial reports, Cencora Inc. (COR) holds total assets worth $78.36 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See COR net assets for net asset value and shareholders' equity analysis.
Cencora Inc. - Total Assets Trend (1994–2025)
This chart illustrates how Cencora Inc.'s total assets have evolved over time, based on quarterly financial data.
Cencora Inc. - Asset Composition Analysis
Current Asset Composition (September 2025)
Cencora Inc.'s total assets of $78.36 Billion consist of 68.2% current assets and 31.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $4.36 Billion | 5.7% |
| Accounts Receivable | $25.23 Billion | 32.9% |
| Inventory | $20.49 Billion | 26.8% |
| Property, Plant & Equipment | $4.09 Billion | 5.3% |
| Intangible Assets | $3.77 Billion | 4.9% |
| Goodwill | $13.68 Billion | 17.9% |
Asset Composition Trend (1994–2025)
This chart illustrates how Cencora Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see COR company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cencora Inc.'s current assets represent 68.2% of total assets in 2025, a decrease from 91.6% in 1994.
- Cash Position: Cash and equivalents constituted 5.7% of total assets in 2025, up from 3.6% in 1994.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 0.0% in 1994.
- Asset Diversification: The largest asset category is accounts receivable at 32.9% of total assets.
Cencora Inc. Competitors by Total Assets
Key competitors of Cencora Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
Cencora Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.92 | 0.92 | 1.07 |
| Quick Ratio | 0.51 | 0.54 | 0.68 |
| Cash Ratio | 0.03 | 0.06 | 0.00 |
| Working Capital | $-4.98 Billion | $-4.52 Billion | $2.47 Billion |
Cencora Inc. - Advanced Valuation Insights
This section examines the relationship between Cencora Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 35.79 |
| Latest Market Cap to Assets Ratio | 0.77 |
| Asset Growth Rate (YoY) | 14.1% |
| Total Assets | $76.59 Billion |
| Market Capitalization | $59.07 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Cencora Inc.'s assets below their book value (0.77x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Cencora Inc.'s assets grew by 14.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Cencora Inc. (1994–2025)
The table below shows the annual total assets of Cencora Inc. from 1994 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $76.59 Billion | +14.14% |
| 2024-09-30 | $67.10 Billion | +7.26% |
| 2023-09-30 | $62.56 Billion | +10.60% |
| 2022-09-30 | $56.56 Billion | -1.36% |
| 2021-09-30 | $57.34 Billion | +29.50% |
| 2020-09-30 | $44.27 Billion | +13.03% |
| 2019-09-30 | $39.17 Billion | +3.99% |
| 2018-09-30 | $37.67 Billion | +6.66% |
| 2017-09-30 | $35.32 Billion | +5.14% |
| 2016-09-30 | $33.59 Billion | +21.10% |
| 2015-09-30 | $27.74 Billion | +28.81% |
| 2014-09-30 | $21.53 Billion | +13.81% |
| 2013-09-30 | $18.92 Billion | +22.50% |
| 2012-09-30 | $15.44 Billion | +3.08% |
| 2011-09-30 | $14.98 Billion | +3.80% |
| 2010-09-30 | $14.43 Billion | +6.35% |
| 2009-09-30 | $13.57 Billion | +11.09% |
| 2008-09-30 | $12.22 Billion | -0.75% |
| 2007-09-30 | $12.31 Billion | -3.71% |
| 2006-09-30 | $12.78 Billion | +12.33% |
| 2005-09-30 | $11.38 Billion | -2.34% |
| 2004-09-30 | $11.65 Billion | -3.21% |
| 2003-09-30 | $12.04 Billion | +7.38% |
| 2002-09-30 | $11.21 Billion | +8.96% |
| 2001-09-30 | $10.29 Billion | +318.59% |
| 2000-09-30 | $2.46 Billion | +19.31% |
| 1999-09-30 | $2.06 Billion | +32.74% |
| 1998-09-30 | $1.55 Billion | -11.04% |
| 1997-09-30 | $1.75 Billion | +46.89% |
| 1996-09-30 | $1.19 Billion | +41.65% |
| 1995-09-30 | $838.70 Million | +17.86% |
| 1994-09-30 | $711.60 Million | -- |
About Cencora Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order … Read more